These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 11016595

  • 1. Alleviation of renal disease and lymphadenopathy in MRL-Fasp(lrcg)/Fas(lprcg) (MR-lpr(cg)) mice neonatally infected with mouse mammary tumor virus encoding superantigen strongly reactive with TCR Vbeta8.2 element.
    Matsuzawa A, Yasuda T, Zhang Y, Nagase H, Yoshimoto T, Kimura M, Tsubura A.
    Viral Immunol; 2000; 13(3):297-311. PubMed ID: 11016595
    [Abstract] [Full Text] [Related]

  • 2. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
    Yasuda T, Yoshimoto T, Tsubura A, Matsuzawa A.
    Cell Immunol; 2001 Jun 15; 210(2):77-86. PubMed ID: 11520074
    [Abstract] [Full Text] [Related]

  • 3. A pivotal role of cell-bound but not soluble CD4 molecules in full development of lupus-like manifestations in MRL-Fas(lprcg)/Fas(lprcg) mice.
    Zhang Y, Yasuda T, Wang CR, Yoshimoto T, Nagase H, Takamoto M, Tsubura A, Kimura M, Matsuzawa A.
    Clin Exp Immunol; 2000 Oct 15; 122(1):124-32. PubMed ID: 11012628
    [Abstract] [Full Text] [Related]

  • 4. Mutational and functional analysis of the C-terminal region of the C3H mouse mammary tumor virus superantigen.
    Wrona TJ, Lozano M, Binhazim AA, Dudley JP.
    J Virol; 1998 Jun 15; 72(6):4746-55. PubMed ID: 9573239
    [Abstract] [Full Text] [Related]

  • 5. Non-exclusive Fas control and age dependence of viral superantigen-induced clonal deletion in lupus-prone mice.
    Papiernik M, Pontoux C, Golstein P.
    Eur J Immunol; 1995 Jun 15; 25(6):1517-23. PubMed ID: 7542196
    [Abstract] [Full Text] [Related]

  • 6. T cells bearing Vbeta8 are preferentially infected with exogenous mouse mammary tumor virus.
    Upragarin N, Nishimura H, Wajjwalku W, Ando Y, Nagafuchi S, Watanabe T, Yoshikai Y.
    J Immunol; 1997 Sep 01; 159(5):2189-95. PubMed ID: 9278306
    [Abstract] [Full Text] [Related]

  • 7. Deletion of CD4+ T cells by mouse mammary tumor virus (FM) superantigen with broad specificity of T cell receptor beta-chain variable region.
    Yoshimoto T, Nagase H, Nakano H, Matsuzawa A, Nariuchi H.
    Virology; 1996 Sep 15; 223(2):387-91. PubMed ID: 8806576
    [Abstract] [Full Text] [Related]

  • 8. Nephritogenicity of the lprcg gene on the MRL background.
    Kimura M, Ogata Y, Shimada K, Wakabayashi T, Onoda H, Katagiri T, Matsuzawa A.
    Immunology; 1992 Jul 15; 76(3):498-504. PubMed ID: 1526655
    [Abstract] [Full Text] [Related]

  • 9. Characterization of mouse mammary tumour virus-induced migration of lymphoid cells into lymph nodes.
    Matsuzawa A, Yasuda T, Sakamoto S, Nagase H, Nakano H, Yoshimoto T.
    Scand J Immunol; 2001 Jun 15; 53(6):553-62. PubMed ID: 11422903
    [Abstract] [Full Text] [Related]

  • 10. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice.
    Schwarting A, Wada T, Kinoshita K, Tesch G, Kelley VR.
    J Immunol; 1998 Jul 01; 161(1):494-503. PubMed ID: 9647261
    [Abstract] [Full Text] [Related]

  • 11. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology.
    Kikawada E, Lenda DM, Kelley VR.
    J Immunol; 2003 Apr 01; 170(7):3915-25. PubMed ID: 12646661
    [Abstract] [Full Text] [Related]

  • 12. B and T cells are required for mouse mammary tumor virus spread within the mammary gland.
    Golovkina TV, Dudley JP, Ross SR.
    J Immunol; 1998 Sep 01; 161(5):2375-82. PubMed ID: 9725233
    [Abstract] [Full Text] [Related]

  • 13. Maternal transfer of infectious mouse mammary tumor retroviruses does not depend on clonal deletion of superantigen-reactive V beta 14+ T cells.
    Penninger JM, Wallace VA, Timms E, Mak TW.
    Eur J Immunol; 1994 May 01; 24(5):1102-8. PubMed ID: 8181521
    [Abstract] [Full Text] [Related]

  • 14. A V beta 8.2-specific superantigen from exogenous mouse mammary tumor virus carried by FM mice.
    Yoshimoto T, Nagase H, Nakano H, Matsuzawa A, Nariuchi H.
    Eur J Immunol; 1994 Jul 01; 24(7):1612-9. PubMed ID: 7913038
    [Abstract] [Full Text] [Related]

  • 15. CD4 expression is important but not essential for infection with exogenous mouse mammary tumor virus.
    Ando Y, Wajjwalku W, Kishihara K, Arai T, Niimi N, Hiromatsu K, Morishima T, Yoshikai Y.
    Immunobiology; 1996 Aug 01; 195(3):376-84. PubMed ID: 8877410
    [Abstract] [Full Text] [Related]

  • 16. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
    Cash H, Relle M, Menke J, Brochhausen C, Jones SA, Topley N, Galle PR, Schwarting A.
    J Rheumatol; 2010 Jan 01; 37(1):60-70. PubMed ID: 19955044
    [Abstract] [Full Text] [Related]

  • 17. Initial stages of mammary tumor virus infection are superantigen independent.
    Pobezinskaya Y, Chervonsky AV, Golovkina TV.
    J Immunol; 2004 May 01; 172(9):5582-7. PubMed ID: 15100301
    [Abstract] [Full Text] [Related]

  • 18. T cell deletion induced by chronic infection with mouse mammary tumor virus spares a CD25-positive, IL-10-producing T cell population with infectious capacity.
    Papiernik M, do Carmo Leite-de-MoraesM, Pontoux C, Joret AM, Rocha B, Penit C, Dy M.
    J Immunol; 1997 May 15; 158(10):4642-53. PubMed ID: 9144476
    [Abstract] [Full Text] [Related]

  • 19. Immunological characterization of C3H mice congenic for Fas(lprcg), C3h/HeJ-Fas(lprcg)/Fas(lprcg).
    Yasuda T, Zhang Y, Nagase H, Kaneko T, Sayama K, Hashimoto H, Matsuzawa A.
    Lab Anim; 2000 Jan 15; 34(1):46-55. PubMed ID: 10759366
    [Abstract] [Full Text] [Related]

  • 20. A V beta 4-specific superantigen encoded by a new exogenous mouse mammary tumor virus.
    Maillard I, Erny K, Acha-Orbea H, Diggelmann H.
    Eur J Immunol; 1996 May 15; 26(5):1000-6. PubMed ID: 8647159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.